Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease

OXFORD, United Kingdom, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced a research collaboration and option agreement with the Icahn

Related Keywords

United Kingdom ,Redmile ,Leicestershire ,New York ,United States ,Simon Conway Natalie ,Susmita Sahoo ,Evox Therapeutics Ltd ,Therapeutics Ltd ,Icahn School ,Mount Sinai ,Icahn Mount Sinai ,Associate Professor ,Antonin De Fougerolles ,Chief Executive Officer ,